The global Induced Pluripotent Stem Cells (iPSCs) revenue was US$ 101.5 million in 2022 and is forecast to a readjusted size of US$ 230.8 million by 2029 with a CAGR of 12.3% during the review period (2023-2029).

and India Induced Pluripotent Stem Cells (iPSCs) Market

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

In India, the Induced Pluripotent Stem Cells (iPSCs) revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.

United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.

The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.

This report focuses on global and India Induced Pluripotent Stem Cells (iPSCs) market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Induced Pluripotent Stem Cells (iPSCs) will continue to grow rapidly in the future.

Global Induced Pluripotent Stem Cells (iPSCs) Scope and Market Size

Induced Pluripotent Stem Cells (iPSCs) market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Induced Pluripotent Stem Cells (iPSCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.

For India market, this report focuses on the Induced Pluripotent Stem Cells (iPSCs) market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Induced Pluripotent Stem Cells (iPSCs) Market Report

Report Metric	Details
Report Name	and India Induced Pluripotent Stem Cells (iPSCs) Market
Forecasted market size in 2029	US$ 230.8 million
CAGR	12.3%
Forecasted years	2023 - 2029
Segment by Type	Human iPSCs Mouse iPSCs
Segment by Application	Academic Research Drug Development and Discovery Toxicity Screening Regenerative Medicine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Induced Pluripotent Stem Cells (iPSCs) Market size in 2029?

Ans: The and India Induced Pluripotent Stem Cells (iPSCs) Market size in 2029 will be US$ 230.8 million.

What is the and India Induced Pluripotent Stem Cells (iPSCs) Market share by region?

Ans: United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the market share of major companies in and India Induced Pluripotent Stem Cells (iPSCs) Market?

Ans: Top 3 companies occupied about 73% market share.

Who are the main players in the and India Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The main players in the and India Induced Pluripotent Stem Cells (iPSCs) Market are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL

What are the Application segmentation covered in the and India Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Applications covered in the and India Induced Pluripotent Stem Cells (iPSCs) Market report are Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others

What are the Type segmentation covered in the and India Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Types covered in the and India Induced Pluripotent Stem Cells (iPSCs) Market report are Human iPSCs, Mouse iPSCs

1 Study Coverage

1.1 Induced Pluripotent Stem Cells (iPSCs) Product Introduction

1.2 Global Induced Pluripotent Stem Cells (iPSCs) Outlook 2018 VS 2022 VS 2029

1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size for the Year 2018-2029

1.2.2 India Induced Pluripotent Stem Cells (iPSCs) Market Size for the Year 2018-2029

1.3 Induced Pluripotent Stem Cells (iPSCs) Market Size, India VS Global, 2018 VS 2022 VS 2029

1.3.1 The Market Share of India Induced Pluripotent Stem Cells (iPSCs) in Global, 2018 VS 2022 VS 2029

1.3.2 The Growth Rate of Induced Pluripotent Stem Cells (iPSCs) Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4 Induced Pluripotent Stem Cells (iPSCs) Market Dynamics

1.4.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends

1.4.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers

1.4.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges

1.4.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Induced Pluripotent Stem Cells (iPSCs) by Type

2.1 Induced Pluripotent Stem Cells (iPSCs) Market Segment by Type

2.1.1 Human iPSCs

2.1.2 Mouse iPSCs

2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018, 2022 & 2029)

2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2029)

2.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018, 2022 & 2029)

2.5 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2029)

3 Induced Pluripotent Stem Cells (iPSCs) by Application

3.1 Induced Pluripotent Stem Cells (iPSCs) Market Segment by Application

3.1.1 Academic Research

3.1.2 Drug Development and Discovery

3.1.3 Toxicity Screening

3.1.4 Regenerative Medicine

3.1.5 Others

3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018, 2022 & 2029)

3.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2029)

3.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018, 2022 & 2029)

3.5 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2029)

4 Global Induced Pluripotent Stem Cells (iPSCs) Competitor Landscape by Company

4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Company

4.1.1 Global Key Companies of Induced Pluripotent Stem Cells (iPSCs), Ranked by Revenue (2022)

4.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Player (2018-2023)

4.2 Global Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR)

4.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR) (2018-2023)

4.2.2 Global Top 5 and Top 10 Largest Companies of Induced Pluripotent Stem Cells (iPSCs) in 2022

4.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Players of Induced Pluripotent Stem Cells (iPSCs) Head office and Area Served

4.4 Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Product and Application

4.5 Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Date of Enter into This Industry

4.6 Companies Mergers & Acquisitions, Expansion Plans

4.7 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Company

4.7.1 Key Players of Induced Pluripotent Stem Cells (iPSCs) in India, Ranked by Revenue (2022)

4.7.2 India Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2021, 2022 & 2023)

5 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region

5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2018-2029)

5.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2018-2023

5.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2024-2029)

6 Americas

6.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2018-2029

6.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type

6.2.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023)

6.2.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029)

6.2.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

6.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

6.3.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023)

6.3.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029)

6.3.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

6.4 Americas Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 United States

6.4.2 Canada

6.4.3 Mexico

6.4.4 Brazil

7 EMEA

7.1 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2018-2029

7.2 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Type

7.2.1 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023)

7.2.2 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029)

7.2.3 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

7.3 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

7.3.1 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023)

7.3.2 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029)

7.3.3 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

7.4 EMEA Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 Europe

7.4.2 Middle East

7.4.3 Africa

8 China

8.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2018-2029

8.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type

8.2.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023)

8.2.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029)

8.2.3 China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

8.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

8.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023)

8.3.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029)

8.3.3 China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

9 APAC (excluding China)

9.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2018-2029

9.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type

9.2.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023)

9.2.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029)

9.2.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

9.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

9.3.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023)

9.3.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029)

9.3.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

9.4 APAC Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2018, 2022 & 2029)

9.4.1 Japan

9.4.2 South Korea

9.4.3 China Taiwan

9.4.4 Southeast Asia

9.4.5 India

10 Key Players Profiles

10.1 Fujifilm Holding Corporation (CDI)

10.1.1 Fujifilm Holding Corporation (CDI) Company Details

10.1.2 Fujifilm Holding Corporation (CDI) Business Overview

10.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction

10.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.1.5 Fujifilm Holding Corporation (CDI) Recent Development

10.2 Ncardia

10.2.1 Ncardia Company Details

10.2.2 Ncardia Business Overview

10.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction

10.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.2.5 Ncardia Recent Development

10.3 Sumitomo Dainippon Pharma

10.3.1 Sumitomo Dainippon Pharma Company Details

10.3.2 Sumitomo Dainippon Pharma Business Overview

10.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction

10.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.3.5 Sumitomo Dainippon Pharma Recent Development

10.4 Astellas Pharma Inc

10.4.1 Astellas Pharma Inc Company Details

10.4.2 Astellas Pharma Inc Business Overview

10.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction

10.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.4.5 Astellas Pharma Inc Recent Development

10.5 Fate Therapeutics, Inc

10.5.1 Fate Therapeutics, Inc Company Details

10.5.2 Fate Therapeutics, Inc Business Overview

10.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction

10.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.5.5 Fate Therapeutics, Inc Recent Development

10.6 Pluricell Biotech

10.6.1 Pluricell Biotech Company Details

10.6.2 Pluricell Biotech Business Overview

10.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction

10.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.6.5 Pluricell Biotech Recent Development

10.7 Cell Inspire Biotechnology

10.7.1 Cell Inspire Biotechnology Company Details

10.7.2 Cell Inspire Biotechnology Business Overview

10.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction

10.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.7.5 Cell Inspire Biotechnology Recent Development

10.8 ReproCELL

10.8.1 ReproCELL Company Details

10.8.2 ReproCELL Business Overview

10.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction

10.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

10.8.5 ReproCELL Recent Development

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.2 Data Source

12.2 Disclaimer

12.3 Author Details

FEATURED COMPANIES

IPS

Fujifilm Holding Corporation (CDI)

Ncardia

Sumitomo Dainippon Pharma

Astellas Pharma Inc

Fate Therapeutics, Inc

Pluricell Biotech

Cell Inspire Biotechnology

Reprocell

List of Tables

Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)

Table 2. Induced Pluripotent Stem Cells (iPSCs) Market Trends

Table 3. Induced Pluripotent Stem Cells (iPSCs) Market Drivers

Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Challenges

Table 5. Induced Pluripotent Stem Cells (iPSCs) Market Restraints

Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Companies of Induced Pluripotent Stem Cells (iPSCs), Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Player, (US$ Million), 2018-2023

Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Player, 2018-2023

Table 13. Global Induced Pluripotent Stem Cells (iPSCs) Companies Market Concentration Ratio (CR5 and HHI)

Table 14. Global Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2022)

Table 15. Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Headquarters and Area Served

Table 16. Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Product and Application

Table 17. Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Date of Enter into This Industry

Table 18. Companies Mergers & Acquisitions, Expansion Plans

Table 19. Key Players of Induced Pluripotent Stem Cells (iPSCs) in India, Ranked by Revenue (2022) & (US$ Million)

Table 20. India Induced Pluripotent Stem Cells (iPSCs) Revenue by Players, (US$ Million), 2021, 2022 & 2023

Table 21. India Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players, 2021, 2022 & 2023

Table 22. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2018-2023) & (US$ Million)

Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2024-2029) & (US$ Million)

Table 25. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023) & (US$ Million)

Table 26. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029) & (US$ Million)

Table 27. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023) & (US$ Million)

Table 28. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029) & (US$ Million)

Table 29. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 30. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2018-2023) & (US$ Million)

Table 31. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2024-2029) & (US$ Million)

Table 32. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023) & (US$ Million)

Table 33. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029) & (US$ Million)

Table 34. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023) & (US$ Million)

Table 35. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029) & (US$ Million)

Table 36. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2018-2023) & (US$ Million)

Table 38. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2024-2029) & (US$ Million)

Table 39. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023) & (US$ Million)

Table 40. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029) & (US$ Million)

Table 41. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023) & (US$ Million)

Table 42. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029) & (US$ Million)

Table 43. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2023) & (US$ Million)

Table 45. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2024-2029) & (US$ Million)

Table 46. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2023) & (US$ Million)

Table 47. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2024-2029) & (US$ Million)

Table 48. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 49. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2018-2023) & (US$ Million)

Table 50. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2024-2029) & (US$ Million)

Table 51. Fujifilm Holding Corporation (CDI) Company Details

Table 52. Fujifilm Holding Corporation (CDI) Business Overview

Table 53. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product

Table 54. Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 55. Fujifilm Holding Corporation (CDI) Recent Development

Table 56. Ncardia Company Details

Table 57. Ncardia Business Overview

Table 58. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product

Table 59. Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 60. Ncardia Recent Development

Table 61. Sumitomo Dainippon Pharma Company Details

Table 62. Sumitomo Dainippon Pharma Business Overview

Table 63. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product

Table 64. Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 65. Sumitomo Dainippon Pharma Recent Development

Table 66. Astellas Pharma Inc Company Details

Table 67. Astellas Pharma Inc Business Overview

Table 68. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product

Table 69. Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 70. Astellas Pharma Inc Recent Development

Table 71. Fate Therapeutics, Inc Company Details

Table 72. Fate Therapeutics, Inc Business Overview

Table 73. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product

Table 74. Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 75. Fate Therapeutics, Inc Recent Development

Table 76. Pluricell Biotech Company Details

Table 77. Pluricell Biotech Business Overview

Table 78. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product

Table 79. Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 80. Pluricell Biotech Recent Development

Table 81. Cell Inspire Biotechnology Company Details

Table 82. Cell Inspire Biotechnology Business Overview

Table 83. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product

Table 84. Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 85. Cell Inspire Biotechnology Recent Development

Table 86. ReproCELL Company Details

Table 87. ReproCELL Business Overview

Table 88. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product

Table 89. ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023) & (US$ Million)

Table 90. ReproCELL Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Induced Pluripotent Stem Cells (iPSCs) Product Picture

Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Size 2018-2029 (US$ Million)

Figure 4. India Induced Pluripotent Stem Cells (iPSCs) Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 5. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2018-2029 (US$ Million)

Figure 6. India Induced Pluripotent Stem Cells (iPSCs) Market Share in Global 2018-2029

Figure 7. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered

Figure 8. Product Picture of Human iPSCs

Figure 9. Product Picture of Mouse iPSCs

Figure 10. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type in 2022 & 2029

Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2029) & (US$ Million)

Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

Figure 13. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Type in 2022 & 2029

Figure 14. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2018-2029) & (US$ Million)

Figure 15. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

Figure 16. Product Picture of Academic Research

Figure 17. Product Picture of Drug Development and Discovery

Figure 18. Product Picture of Toxicity Screening

Figure 19. Product Picture of Regenerative Medicine

Figure 20. Product Picture of Others

Figure 21. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application in 2022 & 2029

Figure 22. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2029) & (US$ Million)

Figure 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

Figure 24. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Application in 2022 & 2029

Figure 25. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2018-2029) & (US$ Million)

Figure 26. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

Figure 27. The Top 5 and 10 Largest Companies of Induced Pluripotent Stem Cells (iPSCs) in the World: Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2022

Figure 28. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region: 2018 VS 2022 VS 2029

Figure 29. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2018-2029)

Figure 30. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2018-2029 (US$ Million)

Figure 31. Americas Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

Figure 32. Americas Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

Figure 33. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 34. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 35. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 36. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 37. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2018-2029 (US$ Million)

Figure 38. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

Figure 39. EMEA Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

Figure 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 41. Middle East Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 42. Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 43. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2018-2029 (US$ Million)

Figure 44. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

Figure 45. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

Figure 46. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2018-2029 (US$ Million)

Figure 47. APAC Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2018-2029)

Figure 48. APAC Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2018-2029)

Figure 49. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 50. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 51. China Taiwan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 52. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 53. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 54. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 55. Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 56. Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 57. Astellas Pharma Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 58. Fate Therapeutics, Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 59. Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 60. Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 61. ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2018-2023)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-29O4198

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Mesenchymal Stem Cell Medium Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10X13372

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Vascular Endothelial Growth Factor Detection Kits Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7D19343

Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Clinical Digital Pathology Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33F15637

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global and India Induced Pluripotent Stem Cells (iPSCs) Market Report & Forecast 2023-2029

Published Date: November 2023

Report Code: QYRE-Auto-28X15696

Global and India Induced Pluripotent Stem Cells (iPSCs) Market Report & Forecast 2023-2029

FEATURED COMPANIES

and India Induced Pluripotent Stem Cells (iPSCs) Market Size

and India Induced Pluripotent Stem Cells (iPSCs) Market

Scope of and India Induced Pluripotent Stem Cells (iPSCs) Market Report

FAQ for this report

What is the and India Induced Pluripotent Stem Cells (iPSCs) Market size in 2029?

What is the and India Induced Pluripotent Stem Cells (iPSCs) Market share by region?

What is the market share of major companies in and India Induced Pluripotent Stem Cells (iPSCs) Market?

Who are the main players in the and India Induced Pluripotent Stem Cells (iPSCs) Market report?

What are the Application segmentation covered in the and India Induced Pluripotent Stem Cells (iPSCs) Market report?

What are the Type segmentation covered in the and India Induced Pluripotent Stem Cells (iPSCs) Market report?

FEATURED COMPANIES

RELATED REPORTS

$8000

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User